Advanced variables and biomarkers for clinical trials

GBS Leiden is a fully capable lab offering extensive possibilities for measures in all of our bioassay systems, ranging from soluble mediators (e.g. multiplex cytokines or chemokines profiling), to changes in cell surface phenotypes, detection of rare cell populations (e.g.detection of circulating cancer cells by imaging flow cytometer Amins Flowsight) or microvesicles, and alterations of mitochondrial function.